CBIO - Catalyst Biosciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5123.37M
Enterprise Value 3-11.82M
Trailing P/E N/A
Forward P/E 1-3.07
PEG Ratio (5 yr expected) 10.19
Price/Sales (ttm)192.16
Price/Book (mrq)0.90
Enterprise Value/Revenue 3-18.42
Enterprise Value/EBITDA 60.47

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-3,971.81%

Management Effectiveness

Return on Assets (ttm)-17.79%
Return on Equity (ttm)-27.58%

Income Statement

Revenue (ttm)642k
Revenue Per Share (ttm)0.09
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -25.35M
Net Income Avi to Common (ttm)-23.07M
Diluted EPS (ttm)-3.09
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)136.15M
Total Cash Per Share (mrq)11.4
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)56.98
Book Value Per Share (mrq)11.47

Cash Flow Statement

Operating Cash Flow (ttm)-23.77M
Levered Free Cash Flow (ttm)-11.24M

Trading Information

Stock Price History

Beta 2.49
52-Week Change 3207.42%
S&P500 52-Week Change 316.98%
52 Week High 337.00
52 Week Low 33.11
50-Day Moving Average 310.77
200-Day Moving Average 321.69

Share Statistics

Avg Vol (3 month) 3709.39k
Avg Vol (10 day) 3184.8k
Shares Outstanding 511.94M
Float 8.3M
% Held by Insiders 11.56%
% Held by Institutions 192.84%
Shares Short (Jul 13, 2018) 4939.31k
Short Ratio (Jul 13, 2018) 40.87
Short % of Float (Jul 13, 2018) 47.98%
Short % of Shares Outstanding (Jul 13, 2018) 47.87%
Shares Short (prior month Jun 15, 2018) 4258.88k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Aug 19, 2015
Ex-Dividend Date 4Aug 20, 2015
Last Split Factor (new per old) 21/15
Last Split Date 3Feb 13, 2017